- Home
- CHRS vs FXAC Comparison
CHRS vs FXAC Comparison
Compare CHRS & FXAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CHRS | FXAC |
|---|---|---|
| Founded | 2010 | 2026 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.1M | 127.6M |
| IPO Year | 2014 | 2026 |
Fundamental Metrics
Financial Performance| Metric | CHRS | FXAC |
|---|---|---|
| Price | $0.77 | $10.14 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $7.75 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 46.5K |
| Earning Date | 11-09-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 472.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $44.19 | N/A |
| Revenue Next Year | $65.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.75 | $10.00 |
| 52 Week High | $2.62 | $10.16 |
Technical Indicators
Market Signals| Indicator | CHRS | FXAC |
|---|---|---|
| Relative Strength Index (RSI) | 35.98 | 63.07 |
| Support Level | N/A | $10.09 |
| Resistance Level | $1.53 | $10.16 |
| Average True Range (ATR) | 0.09 | 0.02 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 7.57 | 36.95 |
Price Performance
Historical ComparisonAbout CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.
About FXAC FortuneX Acquisition Corporation Ordinary shares
FortuneX Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.